Literature DB >> 17166961

Typing and subtyping of Clostridium difficile isolates by using multiple-locus variable-number tandem-repeat analysis.

Renate J van den Berg1, Inge Schaap, Kate E Templeton, Corné H W Klaassen, Ed J Kuijper.   

Abstract

Using the genomic sequence of Clostridium difficile strain 630, we developed multiple-locus variable-number tandem-repeat analysis (MLVA) with automated fragment analysis and multicolored capillary electrophoresis as a typing method for C. difficile. All reference strains, representing 31 serogroups, 25 toxinotypes, and 7 known subtypes of PCR ribotype 001, could be discriminated from each other. Application of MLVA to 28 isolates from 7 outbreaks due to the emerging hypervirulent PCR ribotype 027-pulsed-field gel electrophoresis type NAP1 resulted in recognition of 13 clusters. Additionally, 29 toxin A-negative, toxin B-positive isolates belonging to PCR ribotype 017 from eight different countries revealed eight country-specific clusters. MLVA is a highly discriminatory genotyping method and a new tool for subtyping of newly emerging variants of C. difficile.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17166961      PMCID: PMC1829118          DOI: 10.1128/JCM.02023-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital.

Authors:  A al-Barrak; J Embil; B Dyck; K Olekson; D Nicoll; M Alfa; A Kabani
Journal:  Can Commun Dis Rep       Date:  1999-04-01

Review 2.  Multiple-locus variable number tandem repeats analysis for genetic fingerprinting of pathogenic bacteria.

Authors:  Bjørn-Arne Lindstedt
Journal:  Electrophoresis       Date:  2005-06       Impact factor: 3.535

3.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

Authors:  Vivian G Loo; Louise Poirier; Mark A Miller; Matthew Oughton; Michael D Libman; Sophie Michaud; Anne-Marie Bourgault; Tuyen Nguyen; Charles Frenette; Mirabelle Kelly; Anne Vibien; Paul Brassard; Susan Fenn; Ken Dewar; Thomas J Hudson; Ruth Horn; Pierre René; Yury Monczak; André Dascal
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

4.  Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance.

Authors:  Hanna Pituch; Jon S Brazier; Piotr Obuch-Woszczatyński; Dorota Wultańska; Felicja Meisel-Mikołajczyk; Mirosław Łuczak
Journal:  J Med Microbiol       Date:  2006-02       Impact factor: 2.472

5.  The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome.

Authors:  Mohammed Sebaihia; Brendan W Wren; Peter Mullany; Neil F Fairweather; Nigel Minton; Richard Stabler; Nicholas R Thomson; Adam P Roberts; Ana M Cerdeño-Tárraga; Hongmei Wang; Matthew T G Holden; Anne Wright; Carol Churcher; Michael A Quail; Stephen Baker; Nathalie Bason; Karen Brooks; Tracey Chillingworth; Ann Cronin; Paul Davis; Linda Dowd; Audrey Fraser; Theresa Feltwell; Zahra Hance; Simon Holroyd; Kay Jagels; Sharon Moule; Karen Mungall; Claire Price; Ester Rabbinowitsch; Sarah Sharp; Mark Simmonds; Kim Stevens; Louise Unwin; Sally Whithead; Bruno Dupuy; Gordon Dougan; Bart Barrell; Julian Parkhill
Journal:  Nat Genet       Date:  2006-06-25       Impact factor: 38.330

6.  Use of a novel panel of nine short tandem repeats for exact and high-resolution fingerprinting of Aspergillus fumigatus isolates.

Authors:  Hanneke A de Valk; Jacques F G M Meis; Ilse M Curfs; Konrad Muehlethaler; Johan W Mouton; Corné H W Klaassen
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

7.  Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals.

Authors:  Jane W Marsh; Mary M O'Leary; Kathleen A Shutt; A William Pasculle; Stuart Johnson; Dale N Gerding; Carlene A Muto; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

8.  Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing.

Authors:  P Bidet; F Barbut; V Lalande; B Burghoffer; J C Petit
Journal:  FEMS Microbiol Lett       Date:  1999-06-15       Impact factor: 2.742

Review 9.  Emergence of Clostridium difficile-associated disease in North America and Europe.

Authors:  E J Kuijper; B Coignard; P Tüll
Journal:  Clin Microbiol Infect       Date:  2006-10       Impact factor: 8.067

10.  Clostridium difficile ribotype 027, toxinotype III, the Netherlands.

Authors:  Ed J Kuijper; Renate J van den Berg; Sylvia Debast; Caroline E Visser; Dick Veenendaal; Annet Troelstra; Tjallie van der Kooi; Susan van den Hof; Daan W Notermans
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

View more
  55 in total

1.  An enhanced DNA fingerprinting service to investigate potential Clostridium difficile infection case clusters sharing the same PCR ribotype.

Authors:  Warren N Fawley; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

2.  Clostridium difficile genotypes in piglet populations in Germany.

Authors:  Alexander Schneeberg; Heinrich Neubauer; Gernot Schmoock; Sylvia Baier; Jürgen Harlizius; Hendrik Nienhoff; Katja Brase; Stefan Zimmermann; Christian Seyboldt
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

3.  Molecular genetic basis of ribotyping.

Authors:  Valérie Bouchet; Heather Huot; Richard Goldstein
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

4.  Modified multiple-locus variable-number tandem-repeat analysis for rapid identification and typing of Clostridium difficile during institutional outbreaks.

Authors:  George Broukhanski; Donald E Low; Dylan R Pillai
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

5.  An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.

Authors:  E Bouza; L Alcalá; M Marín; M Valerio; E Reigadas; P Muñoz; M González-Del Vecchio; V de Egea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-05-13       Impact factor: 3.267

6.  Multilocus Variable-Number Tandem-Repeat Analysis of Clostridioides difficile Clusters in Ribotype 027 Isolates and Lack of Association with Clinical Outcomes.

Authors:  Julian R Garneau; Claire Nour Abou Chakra; Louis-Charles Fortier; Annie-Claude Labbé; Andrew E Simor; Wayne Gold; Matthew Muller; Allison McGeer; Jeff Powis; Kevin Katz; Jacques Pépin; Louis Valiquette
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

7.  Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa.

Authors:  B Kullin; J Wojno; V Abratt; S J Reid
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-30       Impact factor: 3.267

8.  Multilocus variable-number tandem-repeat analysis and multilocus sequence typing reveal genetic relationships among Clostridium difficile isolates genotyped by restriction endonuclease analysis.

Authors:  Jane W Marsh; Mary M O'Leary; Kathleen A Shutt; Susan P Sambol; Stuart Johnson; Dale N Gerding; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

9.  Characterisation of Clostridium difficile strains isolated from Groote Schuur Hospital, Cape Town, South Africa.

Authors:  B Kullin; T Brock; N Rajabally; F Anwar; G Vedantam; S Reid; V Abratt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-27       Impact factor: 3.267

10.  Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping.

Authors:  A Indra; S Huhulescu; M Schneeweis; P Hasenberger; S Kernbichler; A Fiedler; G Wewalka; F Allerberger; E J Kuijper
Journal:  J Med Microbiol       Date:  2008-11       Impact factor: 2.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.